The reduction in HAUSP levels amplifies MDM2 degradation through auto-ubiquitination [40]. These MDM2 regulations result in an increase of p53 protein levels and activity. Agitations of ribosomal biogenesis induces ribosomal stress and affects the activity of MDM2 and the function of p53. Ribosomal biogenesis is a coordinated cellular process and a key player in several important cellular activities. A number of RPs, including RPL5, RPL11, RPL23, RPL26, RPS3, RPS7, RPS14, and RPS27/L, have been shown to interact with MDM2, by binding mainly to the central region of MDM2. This interaction inhibits the E3 ubiquitin ligase activity of MDM2 by reducing the flexibility of MDM2 protein, leading to the accumulation and activation of p53 [41]. Although, it is obscure why various RPs bind to and control in reponse to ribosomal stress. Oncogenic activation ARF, a tumor suppressor, negatively regulates MDM2 function. The build-up of MDM2 in the nucleoli is stimulated when the central domain of the MDM2 binds to ARF. The E3 ubiquitin ligase activity of MDM2 is also down-regulated by this interaction [39]. Sudies revealed that ARF levels are heightened as a result of abnormal activation of some oncogenes, like E2F-1, beta-catenin, Myc, and Ras. Thus, MDM2 is isolated from p53 and the activity of MDM2 to negatively regulate p53 is reduced; p53 is in turn activated by the down-regulation of MDM2 function which is vital for tumor
The reduction in HAUSP levels amplifies MDM2 degradation through auto-ubiquitination [40]. These MDM2 regulations result in an increase of p53 protein levels and activity. Agitations of ribosomal biogenesis induces ribosomal stress and affects the activity of MDM2 and the function of p53. Ribosomal biogenesis is a coordinated cellular process and a key player in several important cellular activities. A number of RPs, including RPL5, RPL11, RPL23, RPL26, RPS3, RPS7, RPS14, and RPS27/L, have been shown to interact with MDM2, by binding mainly to the central region of MDM2. This interaction inhibits the E3 ubiquitin ligase activity of MDM2 by reducing the flexibility of MDM2 protein, leading to the accumulation and activation of p53 [41]. Although, it is obscure why various RPs bind to and control in reponse to ribosomal stress. Oncogenic activation ARF, a tumor suppressor, negatively regulates MDM2 function. The build-up of MDM2 in the nucleoli is stimulated when the central domain of the MDM2 binds to ARF. The E3 ubiquitin ligase activity of MDM2 is also down-regulated by this interaction [39]. Sudies revealed that ARF levels are heightened as a result of abnormal activation of some oncogenes, like E2F-1, beta-catenin, Myc, and Ras. Thus, MDM2 is isolated from p53 and the activity of MDM2 to negatively regulate p53 is reduced; p53 is in turn activated by the down-regulation of MDM2 function which is vital for tumor